Efficacy of celecoxib, a cyclooxygenase 2–specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

✍ Scribed by Maxime Dougados; Jehan-Michel Béhier; Irène Jolchine; Andrei Calin; Désirée van der Heijde; Ignazio Olivieri; Henning Zeidler; Hélène Herman

• Publisher: John Wiley and Sons
• Year: 2001
• Tongue: English
• Weight: 94 KB
• Volume: 44
• Category: Article
• ISSN: 0004-3591
• DOI: 10.1002/1529-0131(200101)44:1<180::aid-anr24>3.0.co;2-k